A Phase 3 Trial of Inebilizumab in Generalized Myasthenia GravisNEJM 392:2309-2320, Nowak,R.J.,et al, 2025
B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple SclerosisNEJM 358:676-688, Hauser,S.L.,et al, 2008